Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF

Objective: To investigate the effects of combined medication of nifedipine and magnesium sulfate on the blood pressure, pregnancy-associated plasma protein A (PAPP-A), vascular endothelial growth factor (VEGF), nitric oxide (NO), homocysteine (Hcy) and von Willebrand factor (vWF) in gestational hype...

Full description

Bibliographic Details
Main Authors: Yaohan Wang, Xinyu Zhang, Yaqi Han, Fei Yan, Rui Wu
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:Saudi Journal of Biological Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S1319562X19301445
id doaj-fd6e0c38c3cc436c8dd3cb7735fe2558
record_format Article
spelling doaj-fd6e0c38c3cc436c8dd3cb7735fe25582020-11-25T00:56:09ZengElsevierSaudi Journal of Biological Sciences1319-562X2019-12-0126820432047Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWFYaohan Wang0Xinyu Zhang1Yaqi Han2Fei Yan3Rui Wu4Department of Cardio-Pulmonary Function, Henan Provincial People’s Hospital Heart Centre (Fuwai Central China Cardiovascular Hospital), Zhengzhou 45000, ChinaDepartment of Cardio-Pulmonary Function, Henan Provincial People’s Hospital Heart Centre (Fuwai Central China Cardiovascular Hospital), Zhengzhou 45000, ChinaDepartment of Cardio-Pulmonary Function, Henan Provincial People’s Hospital Heart Centre (Fuwai Central China Cardiovascular Hospital), Zhengzhou 45000, ChinaDepartment of Cardio-Pulmonary Function, Henan Provincial People’s Hospital Heart Centre (Fuwai Central China Cardiovascular Hospital), Zhengzhou 45000, ChinaCorresponding author.; Department of Cardio-Pulmonary Function, Henan Provincial People’s Hospital Heart Centre (Fuwai Central China Cardiovascular Hospital), Zhengzhou 45000, ChinaObjective: To investigate the effects of combined medication of nifedipine and magnesium sulfate on the blood pressure, pregnancy-associated plasma protein A (PAPP-A), vascular endothelial growth factor (VEGF), nitric oxide (NO), homocysteine (Hcy) and von Willebrand factor (vWF) in gestational hypertension patients. Methods: A total of 220 gestational hypertension patients were enrolled as the subjects, and divided into two groups randomly, i.e. the observation group and the control group. In observation group, patients took combined medication of nifedipine and magnesium sulfate, while those in the control group only took magnesium sulfate for treatment. Clinical efficacy, and the changes in blood pressure, PAPP-A, VEGF, NO, Hcy and vWF before and after treatment were compared between two groups. Results: In the observation group and the control group, total effectiveness rates were 92.7% and 70.9%, respectively (p < 0.05). After treatment, we found significant decreases in PAPP-A, VEGF, NO, Hcy and vWF in patients of two groups, with more significant decreases in the observation group (p < 0.05). Incidence rates of the adverse reactions in two groups were 5.5% and 6.4%, respectively, without any statistically significant differences (p > 0.05). In the observation group, patients had fewer complications (p < 0.05). Conclusion: Combined medication of magnesium sulfate and nifedipine can decrease the levels of PAPP-A, VEGF, NO, Hcy and vWF in serum as well as the blood pressure of patients with gestational hypertension, with a reduction in incidence rate of complications and improvement in efficacy. Keywords: Gestational hypertension, Magnesium sulfate, Nifedipine, PAPP-A, VEGF, NO, Hcy, vWFhttp://www.sciencedirect.com/science/article/pii/S1319562X19301445
collection DOAJ
language English
format Article
sources DOAJ
author Yaohan Wang
Xinyu Zhang
Yaqi Han
Fei Yan
Rui Wu
spellingShingle Yaohan Wang
Xinyu Zhang
Yaqi Han
Fei Yan
Rui Wu
Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF
Saudi Journal of Biological Sciences
author_facet Yaohan Wang
Xinyu Zhang
Yaqi Han
Fei Yan
Rui Wu
author_sort Yaohan Wang
title Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF
title_short Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF
title_full Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF
title_fullStr Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF
title_full_unstemmed Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF
title_sort efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on papp-a, vegf, no, hcy and vwf
publisher Elsevier
series Saudi Journal of Biological Sciences
issn 1319-562X
publishDate 2019-12-01
description Objective: To investigate the effects of combined medication of nifedipine and magnesium sulfate on the blood pressure, pregnancy-associated plasma protein A (PAPP-A), vascular endothelial growth factor (VEGF), nitric oxide (NO), homocysteine (Hcy) and von Willebrand factor (vWF) in gestational hypertension patients. Methods: A total of 220 gestational hypertension patients were enrolled as the subjects, and divided into two groups randomly, i.e. the observation group and the control group. In observation group, patients took combined medication of nifedipine and magnesium sulfate, while those in the control group only took magnesium sulfate for treatment. Clinical efficacy, and the changes in blood pressure, PAPP-A, VEGF, NO, Hcy and vWF before and after treatment were compared between two groups. Results: In the observation group and the control group, total effectiveness rates were 92.7% and 70.9%, respectively (p < 0.05). After treatment, we found significant decreases in PAPP-A, VEGF, NO, Hcy and vWF in patients of two groups, with more significant decreases in the observation group (p < 0.05). Incidence rates of the adverse reactions in two groups were 5.5% and 6.4%, respectively, without any statistically significant differences (p > 0.05). In the observation group, patients had fewer complications (p < 0.05). Conclusion: Combined medication of magnesium sulfate and nifedipine can decrease the levels of PAPP-A, VEGF, NO, Hcy and vWF in serum as well as the blood pressure of patients with gestational hypertension, with a reduction in incidence rate of complications and improvement in efficacy. Keywords: Gestational hypertension, Magnesium sulfate, Nifedipine, PAPP-A, VEGF, NO, Hcy, vWF
url http://www.sciencedirect.com/science/article/pii/S1319562X19301445
work_keys_str_mv AT yaohanwang efficacyofcombinedmedicationofnifedipineandmagnesiumsulfateongestationalhypertensionandtheeffectonpappavegfnohcyandvwf
AT xinyuzhang efficacyofcombinedmedicationofnifedipineandmagnesiumsulfateongestationalhypertensionandtheeffectonpappavegfnohcyandvwf
AT yaqihan efficacyofcombinedmedicationofnifedipineandmagnesiumsulfateongestationalhypertensionandtheeffectonpappavegfnohcyandvwf
AT feiyan efficacyofcombinedmedicationofnifedipineandmagnesiumsulfateongestationalhypertensionandtheeffectonpappavegfnohcyandvwf
AT ruiwu efficacyofcombinedmedicationofnifedipineandmagnesiumsulfateongestationalhypertensionandtheeffectonpappavegfnohcyandvwf
_version_ 1725228098229633024